Brazil Insulin Drugs & Delivery Devices Market Share

Statistics for the 2023 & 2024 Brazil Insulin Drugs & Delivery Devices market share, created by Mordor Intelligence™ Industry Reports. Brazil Insulin Drugs & Delivery Devices share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Device Drug Combination Research Diagnostics and Therapeutics Research Diabetes Care Research Insulin Drugs & Delivery Devices Industry in Brazil Market Share

Market Share of Brazil Insulin Drugs & Delivery Devices Industry

The Brazil Insulin Drugs and Delivery Devices Market is moderately consolidated, with few significant and generic players. Mergers and acquisitions between the players recently helped the companies strengthen their market presence. Eli Lilly and Boehringer Ingelheim allied in developing and commercializing Basaglar (Insulin Glargine). Additionally, the players in the recent past helped the companies strengthen their market presence. For example, Novo Nordisk collaborated with Ypsomed to provide better insulin therapy solutions.

Brazil Insulin Drugs & Delivery Devices Market Leaders

  1. Novo Nordisk

  2. Eli Lilly

  3. Sanofi

  4. Medtronic

  5. Becton Dickinson

*Disclaimer: Major Players sorted in no particular order

Brazil Insulin Drugs & Delivery Devices Market Concentration

Brazil Insulin Drugs & Delivery Devices Market Report Snapshots

Insulin Drugs & Delivery Devices Market in Brazil Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)